AAAAAA

   
Results: 1-18 |
Results: 18
Breast cancer in South America: Challenges to improve early detection and medical management of a public health problem
Authors: Schwartsmann, G
Citation: G. Schwartsmann, Breast cancer in South America: Challenges to improve early detection and medical management of a public health problem, J CL ONCOL, 19(18), 2001, pp. 118S-124S
Fractionated doses of oral etoposide in the treatment of patients with AIDS-Related Kaposi sarcoma - A clinical and pharmacologic study to improve therapeutic index
Authors: Sprinz, E Caldas, APF Mans, DR Cancela, A DiLeone, L Dalla Costa, T Schwartsmann, G
Citation: E. Sprinz et al., Fractionated doses of oral etoposide in the treatment of patients with AIDS-Related Kaposi sarcoma - A clinical and pharmacologic study to improve therapeutic index, AM J CL ONC, 24(2), 2001, pp. 177-184
Sentinel lymph node identification and sampling in women with early breastcancer using Tc-99m labelled dextran 500 and patent blue V dye
Authors: Xavier, NL Amaral, BB Cerski, CTS Fuchs, SC Spiro, BL Oliveira, OLM Menke, CH Biazus, JV Cavalheiro, JA Schwartsmann, G
Citation: Nl. Xavier et al., Sentinel lymph node identification and sampling in women with early breastcancer using Tc-99m labelled dextran 500 and patent blue V dye, NUCL MED C, 22(10), 2001, pp. 1109-1117
Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer
Authors: Grivicich, I Mans, DRA Peters, GJ Schwartsmann, G
Citation: I. Grivicich et al., Irinotecan and oxaliplatin: an overview of the novel chemotherapeutic options for the treatment of advanced colorectal cancer, BRAZ J MED, 34(9), 2001, pp. 1087-1103
von Willebrand factor antigen levels in plasma of patients with malignant breast disease
Authors: Rohsig, LM Damin, DC Stefani, SD Castro, CG Roisenberg, I Schwartsmann, G
Citation: Lm. Rohsig et al., von Willebrand factor antigen levels in plasma of patients with malignant breast disease, BRAZ J MED, 34(9), 2001, pp. 1125-1129
Intercellular contact-dependent survival of human A549, NCI-H596 and NCI-H520 non-small cell lung carcinoma cell lines
Authors: Castro, MAA Schwartsmann, G Moreira, JCF
Citation: Maa. Castro et al., Intercellular contact-dependent survival of human A549, NCI-H596 and NCI-H520 non-small cell lung carcinoma cell lines, BRAZ J MED, 34(8), 2001, pp. 1007-1013
Letter to the Editor: Anticancer drugs from nature
Authors: Schwartsmann, G
Citation: G. Schwartsmann, Letter to the Editor: Anticancer drugs from nature, MED PED ONC, 37(1), 2001, pp. 79-80
Multidrug resistance gene expression during the murine ontogeny
Authors: Schiengold, M Schwantes, L Schwartsmann, G Chies, JAB Nardi, NB
Citation: M. Schiengold et al., Multidrug resistance gene expression during the murine ontogeny, MECH AGE D, 122(3), 2001, pp. 255-270
Phase I study of three-times daily oral etoposide in patients with refractory solid tumours
Authors: Schwartsmann, G Caldas, APF Dalla Costa, T Di Leone, L Campos, O Cancela, A Schunemann, H Ferreira, AF Sander, E Mans, DRA
Citation: G. Schwartsmann et al., Phase I study of three-times daily oral etoposide in patients with refractory solid tumours, CLIN DRUG I, 19(5), 2000, pp. 375-383
Protein kinase C-mediated in vitro invasion of human glioma cells through extracellular-signal-regulated kinase and ornithine decarboxylase
Authors: da Rocha, AB Mans, DRA Lenz, G Fernandes, AK de Lima, C Monteiro, VF Goncalves, D Moreira, JCF Brunetto, AL Rodnight, R Schwartsmann, G
Citation: Ab. Da Rocha et al., Protein kinase C-mediated in vitro invasion of human glioma cells through extracellular-signal-regulated kinase and ornithine decarboxylase, PATHOBIOLOG, 68(3), 2000, pp. 113-123
Marine organisms and other novel natural sources of new cancer drugs
Authors: Schwartsmann, G
Citation: G. Schwartsmann, Marine organisms and other novel natural sources of new cancer drugs, ANN ONCOL, 11, 2000, pp. 235-243
Cellular and clinical pharmacokinetic/pharmacodynamic basis for lack of efficacy of 21-day continuous topotecan in patients with untreated advanced adenocarcinoma of the pancreas
Authors: Mans, DRA Di Leone, L Caldas, APF Maino, M Almeida, L Cancela, AS Grivicich, I da Rocha, AB Schwartsmann, G
Citation: Dra. Mans et al., Cellular and clinical pharmacokinetic/pharmacodynamic basis for lack of efficacy of 21-day continuous topotecan in patients with untreated advanced adenocarcinoma of the pancreas, TUMORI, 86(6), 2000, pp. 458-464
A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer
Authors: Schwartsmann, G Schunemann, H Gorini, CNF Ferreira, AF Garbino, C Sabini, G Muse, I DiLeone, L Mans, DR
Citation: G. Schwartsmann et al., A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer, INV NEW DR, 18(1), 2000, pp. 83-91
Tamoxifen inhibits particulate-associated protein kinase C activity, and sensitises cultured human glioblastoma cells not to etoposide but to gamma-radiation and BCNU
Authors: da Rocha, AB Mans, DRA Bernard, EA Ruschel, C Logullo, AF Wetmore, LA Leyva, A Schwartsmann, G
Citation: Ab. Da Rocha et al., Tamoxifen inhibits particulate-associated protein kinase C activity, and sensitises cultured human glioblastoma cells not to etoposide but to gamma-radiation and BCNU, EUR J CANC, 35(5), 1999, pp. 833-839
Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell lines
Authors: Mans, DRA Grivicich, I Peters, GJ Schwartsmann, G
Citation: Dra. Mans et al., Sequence-dependent growth inhibition and DNA damage formation by the irinotecan-5-fluorouracil combination in human colon carcinoma cell lines, EUR J CANC, 35(13), 1999, pp. 1851-1861
Essential drugs for cancer therapy: A World Health Organization consultation
Authors: Sikora, K Advani, S Koroltchouk, V Magrath, I Levy, L Pinedo, H Schwartsmann, G Tattersall, M Yan, S
Citation: K. Sikora et al., Essential drugs for cancer therapy: A World Health Organization consultation, ANN ONCOL, 10(4), 1999, pp. 385-390
Phenotype modulation of cellular UV-sensitivity
Authors: Castro, MA Schwartsmann, G Bernard, EA Moreira, JCF
Citation: Ma. Castro et al., Phenotype modulation of cellular UV-sensitivity, CANCER LETT, 145(1-2), 1999, pp. 65-72
The systemic treatment of AIDS-related Kaposi's sarcoma
Authors: Schwartsmann, G Stefani, S Villarroel, RU
Citation: G. Schwartsmann et al., The systemic treatment of AIDS-related Kaposi's sarcoma, CANC TR REV, 24(6), 1998, pp. 415-424
Risultati: 1-18 |